SHORT COMMUNICATION
International guidelines for the use of methotrexate in rheumatic diseases, particularly in rheumatoid arthritis
More details
Hide details
Online publication date: 2012-06-01
Reumatologia 2012;50(2):91-92
KEYWORDS
ABSTRACT
The article presents the international guidelines for the use of methotrexate in rheumatic diseases, particularly rheumatoid arthritis. It covers eligibility conditions for methotrexate, dosage,
indications and contraindications for its use.
REFERENCES (2)
1.
Visser K, Katchamart W, Loza E, et al. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis 2009; 68: 1086-1093.
2.
Saag K, Teng G, Patkar N, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic Disease-Modifying Antirheumatic Drugs in rheumatoid arthritis. Arthritis Rheum 2008; 59: 762-784.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (
https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.